141 related articles for article (PubMed ID: 17465244)
1. Maspin expression in adenocarcinoma of the ampulla of Vater: relation with clinicopathological parameters and apoptosis.
Blandamura S; D'Alessandro E; Guzzardo V; Giacomelli L; Moschino P; Parenti A; Ninfo V
Anticancer Res; 2007; 27(2):1059-65. PubMed ID: 17465244
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA.
Zhu L; Kim K; Domenico DR; Appert HE; Howard JM
J Surg Oncol; 1996 Feb; 61(2):100-5. PubMed ID: 8606540
[TBL] [Abstract][Full Text] [Related]
3. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?
Marioni G; Giacomelli L; D'Alessandro E; Marchese-Ragona R; Staffieri C; Ferraro SM; Staffieri A; Blandamura S
Am J Otolaryngol; 2008; 29(3):156-62. PubMed ID: 18439947
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
[TBL] [Abstract][Full Text] [Related]
8. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
9. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS
Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
[TBL] [Abstract][Full Text] [Related]
11. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
12. Expression of maspin in colorectal cancer.
Umekita Y; Souda M; Yoshida H
In Vivo; 2006; 20(6B):797-800. PubMed ID: 17203770
[TBL] [Abstract][Full Text] [Related]
13. Aberrant maspin expression in human endometrial cancer.
Murai S; Maesawa C; Masuda T; Sugiyama T
Cancer Sci; 2006 Sep; 97(9):883-8. PubMed ID: 16822296
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
15. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
[TBL] [Abstract][Full Text] [Related]
16. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
18. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
19. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
20. Expression of maspin in papillary Ta/T1 bladder neoplasms.
Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Battanello W; Repele M; Ninfo V
Anticancer Res; 2008; 28(1B):471-8. PubMed ID: 18383887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
